首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1469857

全球細胞分析市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Cell Based Assays Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 234 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2032 年，全球細胞檢測市場的市場規模將從 2023 年的 209.4 億美元達到近 381.4 億美元，2024-2032 年研究期間複合年成長率為 6.89%。

基於細胞的測定是研究細胞過程、相互作用以及對外部刺激或化合物的反應的實驗技術。它們涉及體外培養細胞並測量特定的細胞功能，例如增殖、活力、凋亡、遷移、分化或基因表現。這些檢測方法廣泛應用於基礎研究、藥物發現、毒性測試和藥物篩選，以研究疾病機制、評估藥物療效和安全性以及識別潛在的治療標靶或化合物。

市場動態

對能夠準確預測藥物功效、毒性和安全性的藥物發現和開發工具的需求不斷成長，推動了基於細胞的檢測作為製藥和生物技術研究中有價值的工具的採用。這些測定提供了生理相關性和生物複雜性，使得能夠在更臨床相關的背景下評估候選藥物對細胞過程、訊號路徑和疾病機制的影響。此外，細胞培養技術、自動化、影像技術和高內涵分析的進步提高了細胞檢測的可擴展性、通量和重現性，使其在藥物篩選、毒性測試和個人化醫療應用中不可或缺。

此外，癌症、心血管疾病和神經系統疾病等慢性疾病的流行，刺激了對基於細胞的疾病建模、標靶驗證和生物標記發現檢測的需求，推動了市場擴張。此外，監管機構越來越重視藥物開發中的安全性和有效性評估，再加上 3D 細胞培養模型和器官晶片技術的採用，正在推動先進的細胞檢測平台的創新和採用。製藥公司、合約研究組織 (CRO) 和學術機構之間合作開發和驗證基於細胞的檢測平台推動了市場成長。此外，對精準醫學和個人化治療的投資不斷增加，為患者分層和治療最佳化中基於細胞的檢測創造了機會。然而，來自替代檢測技術的日益激烈的競爭以及對可重複性和可靠性的擔憂可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球細胞檢測市場的每個細分市場進行了包容性評估。基於細胞的檢測產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

基於細胞的分析市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依產品類型

儀器
檢測試劑盒
試劑及耗材
軟體
服務

按申請

藥物發現
基礎研究
預測毒理學
其他

按最終用戶

製藥與生物技術公司
學術機構
合約研究組織
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的細胞檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。細胞偵測市場的主要參與者包括 Danaher Corporation、GE Healthcare Inc.、Charles River Laboratories、Lonza Group Ltd.、Thermo Fisher Scientific Inc.、Merck & Co、PerkinElmer Inc.、Cell Signaling Technology, Inc.、Becton 、迪金森公司、Promega 公司。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：細胞偵測公司的競爭格局

基於細胞的分析市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Danaher Corporation

公司簡介
公司收入
產品
最近的發展

GE Healthcare Inc.

公司簡介
公司收入
產品
最近的發展

Charles River Laboratories

公司簡介
公司收入
產品
最近的發展

Lonza Group Ltd.

公司簡介
公司收入
產品
最近的發展

Thermo Fisher Scientific Inc.

公司簡介
公司收入
產品
最近的發展

Merck & Co.

公司簡介
公司收入
產品
最近的發展

PerkinElmer Inc.

公司簡介
公司收入
產品
最近的發展

Cell Signaling Technology Inc.

公司簡介
公司收入
產品
最近的發展

Becton

公司簡介
公司收入
產品
最近的發展

Dickinson And Company

公司簡介
公司收入
產品
最近的發展

Promega Corporation

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114274

The global demand for Cell Based Assays Market is presumed to reach the market size of nearly USD 38.14 Billion by 2032 from USD 20.94 Billion in 2023 with a CAGR of 6.89% under the study period 2024 - 2032.

Cell-based assays are experimental techniques for studying cellular processes, interactions, and responses to external stimuli or compounds. They involve culturing cells in vitro and measuring specific cellular functions, such as proliferation, viability, apoptosis, migration, differentiation, or gene expression. These assays are widely used in basic research, drug discovery, toxicity testing, and drug screening to investigate disease mechanisms, evaluate drug efficacy and safety, and identify potential therapeutic targets or compounds.

MARKET DYNAMICS

The escalating demand for drug discovery and development tools that can accurately predict drug efficacy, toxicity, and safety profiles drives the adoption of cell-based assays as valuable tools in pharmaceutical and biotechnology research. These assays offer physiological relevance and biological complexity, enabling the assessment of drug candidates' effects on cellular processes, signaling pathways, and disease mechanisms in a more clinically relevant context. Additionally, cell culture techniques, automation, imaging technologies, and high-content analysis advancements have improved cell-based assays' scalability, throughput, and reproducibility, making them indispensable in drug screening, toxicity testing, and personalized medicine applications.

Furthermore, the spurring prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, has spurred the demand for cell-based assays for disease modeling, target validation, and biomarker discovery, driving market expansion. Moreover, regulatory agencies' increasing emphasis on safety and efficacy assessments in drug development, coupled with the adoption of 3D cell culture models and organ-on-a-chip technologies, is fueling the innovation and adoption of advanced cell-based assay platforms. Collaborations between pharmaceutical companies, contract research organizations (CROs), and academic institutions to develop and validate cell-based assay platforms drive market growth. Furthermore, the increasing investment in precision medicine and personalized therapeutics creates opportunities for cell-based assays in patient stratification and treatment optimization. However, increasing competition from alternative assay technologies and concerns about reproducibility and reliability may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell based assays. The growth and trends of cell based assays industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cell based assays market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments
Assay Kits
Reagents & Consumables
Software
Services

By Application

Drug Discovery
Basic Research
Predictive Toxicology
Others

By End-User

Pharmaceutical & Biotech Companies
Academic Institutions
Contract Research Organizations
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Based Assays market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Based Assays market include Danaher Corporation, GE Healthcare Inc., Charles River Laboratories, Lonza Group Ltd., Thermo Fisher Scientific Inc., Merck & Co., PerkinElmer Inc., Cell Signaling Technology, Inc., Becton, Dickinson and Company, Promega Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CELL BASED ASSAYS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY PRODUCT TYPE

5.1. Overview By Product Type
5.2. Historical and Forecast Data
5.3. Analysis By Product Type
5.4. Instruments Historic and Forecast Sales By Regions
5.5. Assay Kits Historic and Forecast Sales By Regions
5.6. Reagents & Consumables Historic and Forecast Sales By Regions
5.7. Software Historic and Forecast Sales By Regions
5.8. Services Historic and Forecast Sales By Regions

6. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Drug Discovery Historic and Forecast Sales By Regions
6.5. Basic Research Historic and Forecast Sales By Regions
6.6. Predictive Toxicology Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data
7.3. Analysis By End-user
7.4. Pharmaceutical & Biotech Companies Historic and Forecast Sales By Regions
7.5. Academic Institutions Historic and Forecast Sales By Regions
7.6. Contract Research Organizations Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CELL BASED ASSAYS COMPANIES

9.1. Cell Based Assays Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CELL BASED ASSAYS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Danaher Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. GE Healthcare Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Charles River Laboratories
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Lonza Group Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Thermo Fisher Scientific Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Merck & Co.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. PerkinElmer Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Cell Signaling Technology Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Becton
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Dickinson And Company
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Promega Corporation
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments